No Data
No Data
Shenzhou Cell (688520): Eight factor dosage turned a loss into a profit in 24Q1
The company achieved revenue of 1,887 billion yuan (+84.46%) in 2023, and achieved revenue of 3.29/4.79/571/508 million yuan in Q1 to Q4, respectively. The company's first production during the period
Shenzhou Cell (688520): Continued rapid release of recombinant eight factors helps the company to turn losses into profits
The company's performance in 2023 grew rapidly. For the first time in the first quarter of 2024, the company achieved revenue of 1,887 billion yuan, an increase of 84.46% over the previous year; net loss to mother was 396 million yuan, and the loss decreased year on year
Shenzhou Cell (688520): 1Q24 net profit reverses loss; focus on the progress of the Eight Factor overseas listing
The 1Q24 results are in line with our expectations. The company announced 1Q24 results: revenue of 613 million yuan, an increase of 86.3% over the previous year; net profit to mother was 74.197 million yuan, which turned a loss into a profit, mainly due to the eight factors of the restructuring of the company's core products (business
Shenzhou Cell (688520): Recombinant factor VIII continues to grow at a high level, and annual results are expected to continue to be released
Key investment points: Revenue for the first quarter of '24 was 613 million yuan, and the eight factor restructuring volume exceeded expectations of 613 million yuan in Q1, an increase of 86.3% over the previous year, and net profit to mother of 74.2 million yuan, an increase of 14 million yuan over the previous year
Express News | Shenzhou Cell: First quarter revenue of 613 million yuan, up 86.3% year on year
Shenzhou Cell (688520): R&D pipeline for rapid release of recombinant factor VIII continues to be rich
Core view On April 12, the company released its 2023 annual report, and the performance was in line with expectations. The company's main product restructuring factor VIII overcame increased competition and procurement adjustments throughout the year, and sales achieved rapid expansion, driving the company's significant performance
No Data